Related Experiment Video

Updated: Jul 9, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Biological approaches to treatment of head and neck cancer

J Nemunaitis1, J O'Brien

  • 1US Oncology, Dallas, Texas 75246, USA. John.Nemunaitis@USOncology.com

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|November 24, 2007
PubMed

Insights

Advanced squamous cell carcinoma of the head and neck (SCCHN) has limited treatment options. Emerging biological therapies, including gene replacement and oncolytic viruses, show promise for improving patient survival.

Area of Science:

  • Oncology
  • Gene Therapy
  • Cancer Immunology

Background:

  • Advanced squamous cell carcinoma of the head and neck (SCCHN) presents limited therapeutic avenues.
  • Conventional chemotherapy does not significantly improve survival rates in SCCHN patients.
  • Recent advancements suggest biological therapies may offer improved outcomes.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for advanced SCCHN.
  • To highlight promising biological and gene-based approaches.
  • To discuss the potential of novel treatments in SCCHN.

Main Methods:

  • Review of recent scientific literature and clinical trial data.
  • Focus on gene therapy, oncolytic viruses, and other biological agents.
  • Exploration of immunotherapeutic targets and antiangiogenic factors.

Main Results:

  • p53 gene replacement with adenoviral vectors and tumor lysis with oncolytic viruses (ONYX-015) are in phase III trials.
  • Gene therapy targeting tumor antigens and co-stimulatory molecules shows potential.
  • Cellular therapies, antiangiogenic factors, and thymidine kinase gene approaches are in preliminary stages.

Conclusions:

  • Novel biological and gene-based therapies represent a promising frontier for advanced SCCHN treatment.
  • Targeting tumor antigens and enhancing immune response are key areas of investigation.
  • Further research and clinical trials are essential to validate these emerging strategies.

More Related Videos

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...